TheraVectys SA France
Research
Date range: 1 February 2022 - 31 January 2023
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for TheraVectys SA published between 1 February 2022 - 31 January 2023 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 1 | 0.01 |
Outputs by subject (Share)
| Subject | Count | Share |
|---|---|---|
| Life Sciences | 1 | 0.01 |
Share output for the past 5 years
| 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| 0.00 | 0.00 | 0.27 | 0.02 | 0.01 |
Nature Strategy Reports
Nature Strategy Reports gives you simple insights to support decisions that impact your organisation
The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.
Collaboration
Date range: 1 February 2022 - 31 January 2023
International vs. domestic collaboration by Share
- 100.00% Domestic (14 institutions)
- 0.00% International (0 institutions)
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with TheraVectys SA by Share*
-
TheraVectys SA and Pasteur Institute
(0.42)
-
TheraVectys SA and Virology
(0.38)
-
TheraVectys SA and Paris Cité University
(0.27)
-
TheraVectys SA and French National Centre for Scientific Research (CNRS)
(0.21)
-
TheraVectys SA and Humoral Immunology
(0.14)
-
TheraVectys SA and National Institute for Health and Medical Research (INSERM)
(0.09)
-
TheraVectys SA and Cordelier Research Center (CRC)
(0.04)
-
TheraVectys SA and Epidémiologie Clinique du Centre d’Investigation Clinique (CIC-EC 1425)
(0.04)
-
TheraVectys SA and Laboratory of Mouse Functional Genetics (GFS)
(0.04)
-
TheraVectys SA and Pasteur-TheraVectys Joint Unit
(0.03)
Top 10 international collaborators with TheraVectys SA by Share*
Relationships
Affiliated joint institutions and consortia
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.